Novartis secured an exclusive worldwide license to Abogen’s Abo2203 and options on additional RNA-platform programs, positioning mRNA-encoded biologic expression as a scalable autoimmune therapeutic ...
AstraZeneca (LSE:AZN) has launched a new AI-driven biologics discovery collaboration with Carterra, announced ahead of ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
In today's Pharmaceutical Executive Daily, Foghorn Therapeutics and Eli Lilly discontinue development of FHD-909, their oral ...
A new U.S. government award has Navitas shares surging. After a string of acquisitions, Lilly is hunting for its next big bet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results